SEC Filing Details
Document Details
Form
Filing Date
Jun 28, 2023
Document Date
Jun 20, 2023
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Cerevel Therapeutics
Issuer
CEREVEL THERAPEUTICS HOLDINGS, INC.
Filer
Burgess Paul D.
Cerevel is now part of AbbVie
Together we will deliver science that takes us closer to meaningful change for people with neurological and psychiatric disorders.